newsfilter
← Latest News
GlobeNewswire·

I-Mab to Participate in Leerink Partners Global Healthcare Conference

ROCKVILLE, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of precision immune-oncology agents for the treatment of